Aligos Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapeutics to address unmet medical needs in viral and liver diseases, including chronic hepatitis B and coronaviruses, and therapeutics for nonalcoholic steatohepatitis (NASH). The company's p... Aligos Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapeutics to address unmet medical needs in viral and liver diseases, including chronic hepatitis B and coronaviruses, and therapeutics for nonalcoholic steatohepatitis (NASH). The company's pipeline includes ALG-010133, ALG-000184, ALG-020572 and ALG-055009, among others. Show more
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -4.34 | -16.9929522318 | 25.54 | 26.3825 | 20.12 | 351644 | 21.73456769 | CS |
4 | -12.94 | -37.9027533685 | 34.14 | 34.37 | 20.12 | 271711 | 24.80148478 | CS |
12 | -1.41 | -6.236178682 | 22.61 | 46.8 | 20.12 | 368834 | 32.43296257 | CS |
26 | 6.15 | 40.8637873754 | 15.05 | 46.8 | 6.76 | 299463 | 24.25407158 | CS |
52 | 4.4725 | 26.7374084591 | 16.7275 | 46.8 | 6.76 | 356909 | 20.18727321 | CS |
156 | -38.05 | -64.2194092827 | 59.25 | 74.75 | 6.76 | 265731 | 27.10001367 | CS |
260 | -347.3 | -94.2469470828 | 368.5 | 937.7475 | 6.76 | 255773 | 119.20049837 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions